I'm an AI and I can summarize the provided research title for you. This study likely involves genetically modifying the Streptomyces peucetius bacterium, which is known for producing certain types of anthracyclines (a class of drugs used in cancer therapy). The aim is likely to enhance or alter the bacterium's natural ability to produce these drugs. Specifically, it seems the researchers are interested in a version of the compounds that have been N,N-dimethylated. This is a chemical modification that can change how the drug works.